SCHEMBL6310846

SCHEMBL6310846

CCOCCOc1ccccc1N

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.68
CYP1A2 P05177 2/20 0.67
CYP2C19 P33261 2/20 0.67
CYP2C9 P11712 1/20 0.67
NCF1 P14598 6/20 0.54
TDP1 Q9NUW8 2/20 0.47
ADRA2B P18089 1/20 0.47
PTGS1 P23219 1/20 0.47
L3MBTL1 Q9Y468 5/20 0.46
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
LMNA P02545 3/20 0.44
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
APP P05067 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYBB P04839 1/20 0.42
NOX5 Q96PH1 1/20 0.42
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17688025 0.98 ALDH1A1 (0.66) ALDH1A1CYP1A2CYP2C19CYP2C9NCF1
SCHEMBL17537502 0.88 CYP1A2 (0.64) ALDH1A1CYP1A2CYP2C19CYP2C9NCF1
SCHEMBL13531826 0.88 CYP1A2 (0.64) ALDH1A1CYP1A2CYP2C19CYP2C9NCF1
SCHEMBL13435256 0.88 CYP1A2 (0.64) ALDH1A1CYP1A2CYP2C19CYP2C9NCF1
SCHEMBL31510123 0.87 CYP1A2 (0.70) ALDH1A1CYP1A2CYP2C19CYP2C9NCF1
SCHEMBL11562109 0.86 L3MBTL1 (0.59) ALDH1A1CYP1A2CYP2C19NCF1TDP1
SCHEMBL29708563 0.85 CYP1A2 (0.72) ALDH1A1CYP1A2CYP2C19CYP2C9NCF1
SCHEMBL864648 0.85 CYP1A2 (0.72) ALDH1A1CYP1A2CYP2C19CYP2C9NCF1
SCHEMBL3372422 0.85 NCF1 (0.55) ALDH1A1CYP1A2CYP2C19CYP2C9NCF1
SCHEMBL6017004 0.85 NCF1 (0.55) ALDH1A1CYP1A2CYP2C19CYP2C9NCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110778-A1 Heterocyclic compounds as ligands of the GABAA receptor YOHANNES DANIEL (US) 2004-06-10 US claimed
EP-1325006-A2 HETEROCYCLIC COMPOUNDS AS LIGANDS OF THE GABA A? RECEPTOR NEUROGEN CORPORATION (US) 2003-07-09 EP claimed
US-20030105081-A1 Heterocyclic compounds as ligands of the GABAA receptor PFIZER INC 2003-06-05 US claimed
WO-2002012442-A2 HETEROCYCLIC COMPOUNDS AS LIGANDS OF THE GABAA RECEPTOR NEUROGEN CORPORATION (US) 2002-02-14 WO claimed
EP-3044208-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2021-12-22 EP disclosed
US-10793555-B2 Oxime ester photoinitiators BASF SE (DE) 2020-10-06 US disclosed
US-20180208583-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-07-26 US disclosed
EP-3044208-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2016-07-20 EP disclosed
WO-2015036910-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2015-03-19 WO disclosed
EP-1957457-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2013-02-27 EP disclosed
US-6949562-B2 Heterocyclic compounds as ligands of the GABAA receptor NEUROGEN CORPORATION (US) 2005-09-27 US disclosed
US-6699959-B2 EXHIBITS A FLOW BEHAVIOR SIMILAR TO THAT OF A LINEAR POLYCARBONATE OF COMPARABLE MOLECULAR WEIGHT OBTAINED BY THE INTERFACE POLYMERIZATION PROCESS. BAYER AKTIENGESELLSCHAFT (DE) 2004-03-02 US disclosed
EP-0937751-B1 Metallized azo ether dyes and optical recording elements comprising the same EASTMAN KODAK CO (US) 2002-07-17 EP disclosed
US-6270943-B1 MULTILAYER; TRANSPARENT GROOVED SUBSTRATE, RECORDING LAYER, LIGHT REFLECTING LAYER, ADHESIVE EASTMAN KODAK COMPANY 2001-08-07 US disclosed
EP-0937751-A1 Metallized azo ether dyes and optical recording elements comprising the same EASTMAN KODAK COMPANY (US) 1999-08-25 EP disclosed
EP-0938085-A1 Optical recording elements containing mixture of metallized azo ether and cyanine dyes EASTMAN KODAK COMPANY (US) 1999-08-25 EP disclosed
US-4216152-A Process for making N-(N'-methylenepyrrolidonyl)-2-substituted anilines GAF CORPORATION (US) 1980-08-05 US disclosed
US-4203901-A Process for making N-(N'-methylenepyrrolidonyl)-2-substituted anilines GAF CORPORATION (US) 1980-05-20 US disclosed
US-4202821-A N-(N'-Methylenepyrrolidonyl)-2-substituted anilines GAF CORPORATION (US) 1980-05-13 US disclosed
US-4178168-A Herbicidal n-(haloacetyl)-n-(n-methylene pyrrolidonyl)-2-oxyalkyleneoxyalkylanilines GAF CORPORATION (US) 1979-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105081-A1 Heterocyclic compounds as ligands of the GABAA receptor GABRB1, GABRP, GABRA1 ALDH1A1 1197/4885CYP1A2 385/4885CYP2C19 354/4885
US-10793555-B2 Oxime ester photoinitiators NR2E3, OXER1, CBR3 ALDH1A1 929/4885CYP1A2 64/4885CYP2C19 107/4885
US-20040110778-A1 Heterocyclic compounds as ligands of the GABAA receptor GABRB1, GABRP, GABRA1 ALDH1A1 1197/4885CYP1A2 385/4885CYP2C19 354/4885
US-20180208583-A1 OXIME ESTER PHOTOINITIATORS NR2E3, OXER1, CBR3 ALDH1A1 929/4885CYP1A2 64/4885CYP2C19 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.